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Objective: Destructive techniques such as histology and biochemical assays are still regarded the gold
standard to study the effects of novel therapies or etiologic aspects of osteoarthritis in small animal
models. These techniques are time-consuming and require many animals. Multi-pinhole single photon
emission computed tomography (MPH-SPECT) is a relatively novel, high resolution imaging technique
which enables assessment of biological processes in real-time and thus it might provide a good sub-
stitute for destructive assessment techniques.
Design: For this study, we assessed mono-iodoacetate (MIA) induced osteoarthritic knees in 18 rats. The
animals were scanned using MPH-SPECT/CT and a diphosphonate labelled with 99m-technetium as the
radioactive tracer to monitor subchondral bone turnover (bone-scan) at 2 (n ¼ 18), 14 (n ¼ 12) and 42
(n ¼ 6) days after injection of MIA. At each time-point six animals were sacriﬁced and also assessed with
high-resolution micro-computed tomography (mCT) and histology.
Results: At 2 days after injection of MIA, the MPH-SPECT/CT already showed elevated bone turnover in
the affected knee, whereas with histology and mCT we could not detect clear alterations at all this time-
point. The increase in bone turnover induced by MIA was elevated further at 14 and 42 days after in-
jection. At this time alterations on histology and mCT scanning also became visible.
Conclusions: MPH-SPECT/CT proved to be a highly sensitive assessment technique for experimental
osteoarthritis in small animal models, detecting real-time changes in bone turnover at a very early time
point, which might make it a valuable technique to measure the direct effect of interventional strategies
on osteoarthritis.
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Multiple small animal models are being used to study osteoar-
thritis1,2. To assess the effect of tested therapies and to study etio-
logic aspects of the disease, destructive measures such as histology
or biochemical assays are still regarded as the gold standard. These
measuring techniques are time-consuming and require many ani-
mals, which have to be sacriﬁced at multiple time points to get
insight into the progression of the disease. In vivo longitudinal
assessment of osteoarthritis in these animals might accelerate
research and provide additional information of the disease in each
individual animal.T.M. Piscaer, Department of
Molewaterplein 50, 3015 GE
: 31-104089415.
aer).
s Research Society International. PA few small animal imaging techniques are already imple-
mented for the longitudinal assessment of osteoarthritis3 of which
micro-computed tomography (mCT)4,5 and magnetic resonance
imaging (MRI)6 are the most well-known.
Recently, high resolution molecular imaging techniques became
available for small animal imaging, including multi-pinhole single
photon emission computed tomography (MPH-SPECT)7 and micro-
positron emission tomography (micro-PET)8. These functional
imaging modalities provide the opportunity to assess biological
processes in real-time in contrast to structural imaging modalities
(e.g., CT or MRI) which provide the results of these processes over a
longer period of time. Besides, imaging of radioactive labelled
molecules increases sensitivitymore than amillion times compared
to the conventional imagingmethods. This allowsmonitoring short-
time responses of cells and tissues to interventional strategies and
following the duration of the process over time.ublished by Elsevier Ltd. All rights reserved.
T.M. Piscaer et al. / Osteoarthritis and Cartilage 21 (2013) 882e888 883In the clinic, SPECT scanning using radioactive labelled poly-
phosphonates already proved to be highly sensitive for detecting
and monitoring osteoarthritis9e11. It correlates with clinical pain,
osteophytes on radiographs12, meniscus injury13,14, osteochondral
lesions15 and arthroscopic ﬁndings16.
Though bone-scanning is highly sensitive for detecting and
monitoring osteoarthritis, the technique has never been applied for
the assessment of experimental osteoarthritis in rodents. The main
reason may be the lack of high spatial resolution of the clinical
technique, which is approximately 0.5e1 cm. In rats, the radioactive
signal of bone turnover of the growth plate interferes with the
adjacent signal of the altering subchondral bone turnover. As rats
are known to have an active growth plate almost during their entire
life span, it is a real challenge to monitor experimental osteoar-
thritis using bone scans and not possible with the spatial resolution
that clinical systems offer.
By placing a pinhole collimator in front of the detector, higher
spatial resolution can be obtained in SPECT7. The consequence of the
use of a pinhole collimator is the decrease in sensitivity as multiple
gamma rays are rejected from the detector by the collimator. To
overcome this problem, collimators containing multiple pinholes
have been developed17. As a consequence, dedicated small animal
MPH-SPECT cameras can reach sub-millimetre resolution within
reasonable scanning time. We hypothesized that MPH-SPECT will be
a suitable and highly sensitive method for the assessment of sub-
chondral bone turnover in a rat model for osteoarthritis.
Materials and methods
Experimental animal model
All procedures were approved by the Animal Ethical Committee
of the Erasmus Medical Centre, Rotterdam, The Netherlands. We
used the mono-iodoacetate (MIA) rat model for OA18. MIA inhibits
glyceraldehyde-3-phosphate dehydrogenase activity, and thereby
diminishes chondrocyte metabolism, resulting in chondrocyte
death and lesion formation. This model is known to target the joint
cartilage and is not known for its inﬂuence on the subchondral
bone directly. One milligramMIA (SigmaeAldrich) was dissolved in
50 ml sterile saline. We injected the MIA solution into the right
knees of 24, male Wistar rats (Harlan, Horst, The Netherlands) at
the age of 12 weeks. To produce a control condition, an equal
amount of sterile saline was injected into the left knees. The in-
jections were performed using a 27 gauge needle, while the rats
were under isoﬂurane anaesthesia.
Experimental setup
Group 1 (n ¼ 18)
This group is used for the assessment of subchondral bone turnover
using MPH-SPECT/CT, comparison to mCT assessment of subchondral
bone and histological cartilage assessment.
On day 2 (n ¼ 18), 14 (n ¼ 12) and 42 (n ¼ 6) after MIA injection,
subchondral bone metabolism of the knee was assessed using an
animal MPH-SPECT/CT as described below. Two days after each
MPH-SPECT/CT assessment, six animals were sacriﬁced and their
hind limbs harvested to assess bone architectural alterations and
cartilage degeneration using high-resolution mCT and histology.
Group 2 (n ¼ 6)
This group was used to evaluate of the conventional histological
methods could detect changes in bone alteration at an early time point
after the induction of experimental OA.
Additional histological staining as TRAP staining and calcein
green labelling was used. On day 2 after MIA injection, subchondralbone metabolism of the knee was assessed using an animal MPH-
SPECT/CT as described below. These six rats were injected subcu-
taneously with the ﬂuorescent dye calcein (25 mg/Kg bodyweight)
direct prior to MPH-SPECT/CT scanning. Two days after each MPH-
SPECT/CT assessment, all animals were sacriﬁced and their hind
limbs harvested to assess bone alterations using histological TRAP
and calcein staining.
Small animal MPH-SPECT/CT scanning (group 1 and 2)
For MPH-SPECT/CT scanning, we intravenously injected
185 MBq 99mTechnetium-methylene diphosphonate (99mTc-MDP)
(Draxis Pharmaceuticals Inc., Quebec, Canada). 99mTc-MDP in-
corporates into the hydroxyapatite of the exposed osteoid at sites of
bone formation and destruction and can be used to visualize the
amount and location of bone turnover. The injection procedure was
performed under isoﬂurane anaesthesia.
Four hours after injection of 99mTc-MDP, an MPH-SPECT scan
(NanoSPECT/CT, Bioscan Inc., Washington DC.) was made. In addi-
tion, a mCT scan at a relatively low resolution was performed to
obtain anatomical information on the localization of the radionu-
clide. The Nano-SPECT/CT contains four gamma cameras that rotate
helically around the animal. Each gamma camerawas ﬁttedwith an
application-speciﬁc tungsten collimator with nine pinholes of each
2 mm in diameter (so-called rat collimator). These apertures pro-
vide a reconstructed resolution below 1.6-mm. at 140 keV. The
energy peak for the cameras was set at 140 keV (10%), which
resembles the energy peak of 99m-Tc. Twenty-four projections per
scanweremade (rotation angle¼ 15), at an exposure time of 300 s
per projection, resulting in a total acquisition time of 30 min per
animal. For anatomical information of the localization of the 99mTc-
MDP, an additional CT scan of the rat knees was obtained at a
resolution of 200 mm. The whole procedure SPECT and CT scanning
took 35 min per animal.
During scanning, the animals were under isoﬂurane anaes-
thesia. We placed the animals in the supine position on the heated
scan bed with their hind paws stretched and ﬁxed in a custom-
made wooden holder.
The SPECT data were reconstructed iteratively with the HiSPECT
software (Bioscan). The MPH-SPECT and CT data were fused auto-
matically using fusion software (InVivoScope, Bioscan).
After reconstruction, the knees were reoriented in the same
direction and two regions of interest of equal size were determined
on the SPECT/CT scan: the medial femoral condyle and the lateral
femoral condyle. The region of interest (ROI) contained the whole
subchondral bone plate, deﬁned from the joint space at its distal
border to 1.2 mm in the cranial direction (see Fig. 1). All regions of
interest were of exact the same size and shape. Total radioactivity in
each region of interest was determined and compared to its contra-
lateral counterpart (left-right). Differences in activation between
the MIA injected side (right knee) and the control side (left knee)
were statistically evaluated using the Wilcoxon matched pairs
signed rank test. Results of P < 0.05 were considered as statistically
signiﬁcant.
High-resolution mCT scanning (group 1)
After harvesting of the hind-paws at end-point, we made an
ex-vivo, high-resolution mCT scan of the knees to assess archi-
tectural alterations of the subchondral bone. The knees were
scanned at an isotropic resolution of 18 mm (Skyscan1076, Sky-
scan, Kontich, Belgium). After reconstruction of the mCT data, we
separated calciﬁed tissue from non-calciﬁed tissue using an
automated local threshold algorithm19. The scans were reor-
iented in three dimensions such that all femurs were equally
Fig. 1. Example of anatomic image of mCT, an MPH-SPECT image and the fused MPH-SPECT/CT image in which the anatomical localization of the tracer can be determined. In the
fused MPH-SPECT/CT image the region of interest for determining radioactivity uptake in the medial femoral condyle is shown.
T.M. Piscaer et al. / Osteoarthritis and Cartilage 21 (2013) 882e888884matched and the intercondylar roof was placed in the horizontal
position. The same two regions of interest in the medial and
lateral femoral condyle were determined in the mCT data. The
ROI of the medial femoral condyle contained 90 crossections or
1.6 mm from the most distal part of the femur up to proximal,
ending just below the intercondylar roof. The ROI for the smaller
lateral condyle contained 70 crossections or 1.2 mm from the
most distal part of the femur towards proximal, ending just
below the intercondylar roof. The cortical shell (subchondral
cortical plate) and the underlying cancellous bone were sepa-
rated using in-house software. From these data, morphometric
parameters were measured using the freely available software
package 3D-Calculator (http://www.erasmusmc.nl/47460/
386156/downloads). The following 3D morphometric parame-
ters were determined: subchondral cortical plate volume, sub-
chondral cortical plate thickness, trabecular bone volume/
marrow volume (BV/TV) and trabecular thickness.Fig. 2. Representative examples of MPH-SPECT/CT scans of the knees of one animal
using one ﬁxed threshold; the MIA injected knee as well as its contra-lateral saline
injected knee is shown at 2, 14 and 42 days after injection. The radioactive signal at the
medial femoral condyle in the MIA injected knees can be separated from the radio-
active signal of the growth plates in the MIA injected knees at all time-points.Histological assessment
Group 1
Knee joints were decalciﬁed for 2 weeks using 10% formic acid
dissolved in aqua dest. After decalciﬁcation the joints were parafﬁn
embedded and frontal sections of 6 mm were cut at every 500 mm.
Safranin O stained sections were used to assess cartilage damage
and the semi-quantitative grading and staging system devised by
the OARSI Working Group20 was used as a guide to describe the
cartilage damage patterns.
Group 2
The knees of these rats were not decalciﬁed but imbedded in
methylmetacrylate. Transversal sections from the middle part of
knee were obtained in the transversal direction. One section was
stained using a TRAP staining to evaluate osteoclast presence.
Another section was examined for presence of calcein green
using an epiﬂuorescent microscope (Axiovert 200MOT/Carl Zeiss,
Gottingen, Germany). Equal photographs were taken of the medial
femoral condyles, from the border of the subchondral bone to
1.2 mm towards the cranial direction. The Photographs were pro-
cessed into binary imaged using one ﬁxed threshold. The surface
area of the calcein green staining was calculated. Right medial
condyles were compared to their left counterparts using the Wil-
coxon matched pairs signed rank test.
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MPH-SPECT/CT
The MPH-SPECT/CT technique enabled us to longitudinally
assess the distribution and amount of 99mTc-MDP uptake in three
dimensions at an isotropic resolution of approximately 800 mm. On
the co-registered CT images we could determine the anatomical
localization of the radioactivity (Fig. 1).
All scans showed high 99mTc-MDP uptake in the femoral and
tibial growth plate in all scans. 99mTc-MDP uptake of the sub-
chondral bone region of the femoral condyles could be separated
from the adjacent activation of the growth plate in all rats (Fig. 2) at
all time points. We could not detect a separate activation spot on
the subchondral bone region of the tibia due to the interference of
the activity of the nearby growth plate (Fig. 2).
At t¼ 2days, themedial femoral condyleof theMIA injectedknees
showedanaverage increaseof53%of 99mTc-MDPuptakecompared to
the contra-lateral, saline injected knees (P < 0.001). At 14 days after
MIA injection the amount of uptake of theMIA injected kneewas 56%
(P < 0.001) higher than its contra-lateral counterpart. At day 42, the
amount of uptake in the medial condyle increased to a mean differ-
ence of 105% (P¼ 0.0313). The lateral femoral condyle of the affected
side did not show alterations in uptake at day 2 and 14, though at 42
days after MIA injection it showed a trend towards an increase in
uptake compared to its counterpart (38%) (P ¼ 0.25) (Fig. 3).
The animals of group 2 showed an average increase in tracer
uptake of the medial femoral condyle of 19% compared to their
contralateral side (P ¼ 0.03). All animals showed higher amount of
uptake on the MIA injected side [Fig. 6(B)].Fig. 3. Dot plots show changes in radioactivity uptake and cortical BV of the MIA injected kn
after injection. A: medial femoral condyles assessed by MDP-SPECT/CT, B: lateral femoral c
femoral condyle assessed by mCT.High-resolution mCT
The mCT allowed us to detect which bone structures were altered
in the time period afterMIA injection. At day 4 afterMIA injection, no
bone morphometric differences could be detected between the MIA
injected and the saline injected knees. At 14 days after injection of
MIA, the subchondral boneplate of the trochlea seemed to get eroded
at some locations (Fig. 4). Also, at this time-point no 3D-morpho-
metric differences in the condyles could be detected. At 44 days after
MIA injection, a trend towards subchondral bone plate changes in the
medial as well as the lateral condylewere detected. The subchondral
bone plate volume of the medial femoral condyle was 11% (P < 0.13)
lower compared to its contra-lateral counterpart and the BV of the
lateral subchondral plate of femoral condyle was 10% lower in the
MIA injected knee than its counterpart (P< 0.13) (Figs. 4 and 5). There
was no signiﬁcant difference in subchondral bone plate thickness
detected and no differences in the determined trabecular 3D
morphometric parameters we found at any time point.
Histology
Group 1, cartilage assessment
The cartilage of the medial and lateral femoral condyles of the
saline injected knees were unaffected at all time-points (4, 16 and
44 days post saline injection). An intact, smooth surface was
observed and the chondrocytes were mostly organized in three
well-ordered zones. No enlargements or proliferate changes were
detected. We could not distinguish the cartilage from the MIA
injected knees at t ¼ 4 days after injection from the cartilage of the
control knees. At 16 days after MIA injection the cartilage of theee compared to its contralateral counterpart at 2, 14 and 42 days and 4, 16 and 44 days
ondyles assessed by SPECT/CT, C: medial femoral condyle assessed by mCT, D: lateral
Fig. 4. Representative images of high resolution in-situCTscans of one animal of the femoral condyles of itsMIA injected aswell as of its contra-lateral saline injected knee. Images of 4,16
and 44 days after injection are shown, in transversal as well as in sagittal direction. Note the bony erosions and osteophyte formation in the MIA injected knees as shown by arrows.
Fig. 5. Representative safraninO stained histological sections of saline injected aswell as
MIA injected knees of themedial aswell as the lateral femoral condyle. The saline injected
knees are shown at 4 days after injection and theMIA injected knees at 4, 16 and 44 days
after injection. Note the increasing discolorization, increasing cell disorganization and
increase in cell death, and the formation of ﬁssures in time of the MIA injected knees.
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of matrix colouration and clustering of chondrocytes (grade 1e2,
stage 3, score: 4.5). There was also superﬁcial ﬁbrillation and slight
discoloration detected of the cartilage of the lateral femoral
condyle, though it seemed less than on the medial side (grade 1e2,
stage: 1, score: 1.5). At 44 days after MIA injection the cartilage of
the medial femoral condyle was largely discolored, there was cell
disorganization and large vertical ﬁssures were detected (grade 3,
stage 4, score 12). The lateral femoral condyle showed the same
pattern as the medial femoral condyle at 44 days after MIA injec-
tion (Fig. 6).
Group 2, bone assessment at an early time point
The animals of group 2 showed an average of 19% increase in
ﬂuorescent signal compared to their contralateral counterparts at 4
days after MIA injection (P ¼ 0.09). Five out of six animals showed
an increase in ﬂuorescent signal. One animal showed a decrease in
ﬂuorescent signal [Fig. 6(B)]. The TRAP staining showed large
numbers osteoclasts present at the zones around the growth plate.
Though the area of the subchondral bone showed a few (0e3) os-
teoclasts in the saline as well as in the MIA injected knees, there
could not be any reliable difference detected.Discussion
MPH-SPECT/CT proved to be a sensitive technique capable of
detection and monitoring of experimental knee osteoarthritis in a
rat. We showed for the ﬁrst time that it is possible to monitor
subchondral bone metabolism alterations in a rat model for oste-
oarthritis in vivo and assess alterations in the intensity of this
process over a longer time period. The anatomical CT reference
provided the information to locate the tracer uptake in the different
compartments of the knee. The high resolution of the MPH-SPECT
allowed separation of activation of the subchondral regions in the
femoral condyles and that in the active growth plate, and thus
allowed quantiﬁcation of bone turnover of the speciﬁc subchondral
bone regions of the distal femur.
Fig. 6. A. Representative calcein green ﬂuorescent images of subchondral bone of a saline injected knee and a MIA injected knee at 4 days after MIA injection. The subchondral
border is located at the right side of the image. B. Dot-plots of differences in radioactivity uptake and surface area of calcein green signal of the medial femoral condyles. MIA
compared to their contralateral counterparts injected with saline. Changes are represented in percentages.
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involvement of many components of the joint and surrounding
tissues, such as synovium, cartilage, bone, tendons and muscles.
The time duration between injection and scanning of 4 h provided
clearance of the soft tissues of the tracer, allowing imaging of the
incorporated MDP into the bone only, providing a high target to
background ratio.
In clinical use, SPECT bone scanning has proved to be more
sensitive to early alterations in the joint tissues and acute knee pain
than anatomic or structural imaging modalities (e.g., MRI, CT or
X-ray). Therefore the method can be used for assessment of acute
traumatic pain as a consequence of ligament or meniscal injuries,
derangement and early OA13,14,21. MRI ﬁndings of bone marrow le-
sions (BML) also proved to have good agreement with an increased
uptake in bone scintigraphy22,23. This underlines the usefulness of
detecting the early bone alterations as a consequence of alterations
in the joint. The detection of early alterations in bone remodelling in
clinical ﬁndings agreed with our ﬁndings of the increase in tracer
uptake. Already in the ﬁrst assessment, as early as 48 h after in-
jection of MIA we found signiﬁcant alterations in the subchondral
bone, earlier as the detected alterations on mCT of bone and the
histological assessment of the femoral cartilage and bone. The
response of the bone on the induction the experimental osteoar-
thritis by injection of MIA might be the result of multiple direct or
indirect effects. MIA primarily affects the chondrocytes. As a
response to MIA, chondrocytes change their metabolic activity.
Therefore the mechanical properties of the surrounding cartilage
matrix may consequently be altered, e.g., by loss of glycosamino-
glycans (GAG). It is however hard to imagine that this would already
occur as early as 48 h, at a time point wherewe cannot see any GAG
loss on the qualitative histological score. Therefore, an alternative
explanation might be that immediately after MIA injections the
chondrocytes synthesize a number of products e.g., IGF-1, TNF-a and
IL-6 related to chondrocyte apoptosis that can leak to the sub-
chondral bone and induce bone turnover. Furthermore, MIA might
have a direct effect on osteoclasts or osteoblasts and directly cause a
quick response in bone-turnover. Further research has to be per-
formed to answer these hypotheses using other models for osteo-
arthritis (e.g., using the ACLT and/or groove model).
Though we could not detect statistically signiﬁcant changes in
the histological sections, there was a clear trend towards more
calcein green signal detected (Fig. 6). It would be reasonable to
assume that if more animals were used or more section were
analyzed for the assessment of bone changes on histology, a sta-
tistical difference would be detected between the saline and the
MIA injected knee at 4 days after injection.As shown by Christiansen et al. early changes in a mouse model
of osteoarthritis could be detected at an early time point after in-
duction of traumatic osteoarthritis24.
Though the technique seems feasible to use for OA research
the effect of the application of radiation to the animalmust be tested
in future studies. Alsowe could not eliminate the possibility that the
injection of saline to the contralateral knee could have affected the
bone turnover of the control condition for we did not use a control
condition in which an animal was not injected with MIA or saline.
Besides its sensitivity to detect bone changes, the use of MPH-
SPECT has other advantages in OA research. Preparation of the
tracer, injection, scanning and quantiﬁcation of the data can be
performed for a batch of animals (n ¼ 6) easily in 1 day. Besides the
assessment of bone turnover with MPH/SPECT nuclear imaging
provides the possibility to assess multiple tracers at one time by the
use of different radio-nuclides. The development of radioactive
tracers for the assessment of osteoarthritis is not extensively
investigated, though some tracers for targeting cartilage and
inﬂammation have been proposed earlier25,26.
99m-Tc-MDP enhanced MPH-SPECT/CT is a new tool for the
assessment of osteoarthritis in small animalmodels,which proved to
be highly sensitive for the detection of alterations in bone turnover at
an extremely early time point in disease progression. Thismakes this
technique valuable for the assessment of new intervention strategies
for OA and might give more insight in OA aetiology.
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